Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Recent & Breaking News (GREY:TBPMQ)

Tetra Bio-Pharma Announces the Signature of a Letter of Intent to Monetize GrowPros and its Late Stage ACMPR Application

Marketwired December 21, 2017

Tetra Bio-Pharma Reinforces its Development Program by Signing Research & Development Agreement with Constance Therapeutics and Receiving Financial Support from NSERC

Marketwired December 13, 2017

Tetra Bio-Pharma provides update on status of its Phase 3 Clinical Trial Application of Lead Drug Candidate PPP001

MarketWire Canada December 9, 2017

Tetra Bio-Pharma Inc. Opens the Market

Canada NewsWire December 6, 2017

Tetra Bio-Pharma Opens Markets at TSX Listing Ceremony

MarketWire Canada December 6, 2017

Tetra Bio-Pharma accelerates submission of New Drug Application to FDA & Expects to Commercialize Dronabinol XL Tablet Ahead of Schedule(1) in the US

MarketWire Canada November 28, 2017

Tetra Bio-Pharma's Business Model and Commercialization Strategy In Line with the Canadian Government's Proposed Approach to the Regulation of Cannabis

MarketWire Canada November 22, 2017

Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria

Marketwired November 16, 2017

Tetra Bio-Pharma Concludes its First Sale of Rx Princeps(TM) Inhalation Device

MarketWire Canada November 9, 2017

Tetra Bio-Pharma Goes After the Cannabis Oil Medical Market and Launches a Phase 4 Trial with Cannabis Oils in Partnership with Santé Cannabis

Marketwired October 26, 2017

Tetra Bio-Pharma Hires Medical Science Liaison to Promote Rx Princeps(TM) and Presents its New Corporate Image

MarketWire Canada October 19, 2017

Tetra Bio-Pharma Signs Agreement with Partner Aphria to Start Promoting Rx Princeps(TM), its Medical Cannabis Blend, under ACMPR

MarketWire Canada October 18, 2017

Tetra Bio-Pharma Continues Forward into the Veterinary Ophthalmology Market by Entering into an Agreement with Drs. Cullen and Webb

MarketWire Canada October 13, 2017

Tetra Bio-Pharma Selected to Present at Prestigious BIO Investor Forum In San Francisco October 17-18

MarketWire Canada October 4, 2017

Tetra Engages in Innovative Air Analysis and Development of Specific Air Cleaning Devices with AES Environment for the Commercialization of PPP001 and for Marijuana Consumer Market

MarketWire Canada September 28, 2017

Tetra Bio-Pharma to engage in co-development and distribution partnership with major healthcare specialty distributor

MarketWire Canada September 20, 2017

Tetra Bio-Pharma getting ready to file a clinical trial application to initiate phase 3 clinical trial on terminal cancer patients in the coming weeks

Marketwired September 18, 2017

Tetra Bio-Pharma accelerates its clinical research program in the veterinary market by entering into agreement with Dr. Louis-Philippe de Lorimier

Marketwired September 11, 2017

Tetra Bio-Pharma to Attend the 10th Annual International Partnering Conference - BioPharm America

Marketwired September 7, 2017

Tetra Bio-Pharma to Benefit from Intellectual Properties Created within the Cannabis Health Research Chair from the University of New Brunswick

MarketWire Canada August 31, 2017